Beijing CTSmed Co. Ltd   Report issue

For profit Phase 4
Founded: Beijing China (2007)

Organization Overview

First Clinical Trial
2014
NCT02145546
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

amiodarone (cordarone) (1 trial)

propafenone (rythmol) (1 trial)

sotalol (betapace) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3